Financials

  • Market Capitalization 393.94 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-2.58
Índice preço/fluxo de caixa
-6 934.07

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
2988
DRUG
Bright Minds Biosciences Inc. - common stock
53.83 USD-0.41%+6.89%-14.32%-12.29%411.03 M USD
2993
MPLT
MapLight Therapeutics, Inc. - Common Stock
8.82 USD-0.11%-5.26%-32.57%-53.58%409.05 M USD
3015
GALT
Galectin Therapeutics Inc. - Common Stock
3.93 USD-0.25%+5.08%-0.51%-18.46%396.34 M USD
3023
IRD
Opus Genetics, Inc. - Common Stock
4.71 USD+1.29%+6.56%-21.76%+26.61%391.85 M USD